Randomized Trial of Different Loading Dose of Ticagrelor for Antiplatelet Effect in Patients With Non -ST-segment Elevation ACS Undergoing Percutaneous Coronary Intervention
Phase of Trial: Phase IV
Latest Information Update: 20 Feb 2017
Price : $35 *
At a glance
- Drugs Ticagrelor (Primary)
- Indications Acute coronary syndromes
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 20 Feb 2017 Trial design and rationale of the APELOT Trial published in Medicine.
- 17 Dec 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.